CE-Marked Blood Analyzer Interfaces with Popular Data Management System
|
By LabMedica International staff writers Posted on 12 Sep 2016 |
|
Image: The Proxima blood gas analysis system can be connected into LIS and data management systems of Conworx (Photo courtesy of Sphere Medical).
Unique point-of-care (POC) connectivity to a widely used information transfer and management system is now available for a novel in-line arterial blood analyzer that supports rapid and frequent measurement of blood gases, electrolytes, and metabolites to monitor critical care patients without leaving bedside.
The CE-marked Proxima blood analysis device from Sphere Medical (Cambridgeshire UK) can now be connected into the family of laboratory information system interfaces and data management solutions from Conworx Technology (Berlin, Germany). This is a significant development since it provides near real-time feedback and ensures seamless transfer of test results from Proxim directly into laboratory information management systems (LIMSs) and electronic patient records – a key requirement for the successful implementation of POC testing.
Proxima supports patient critical care, including in the ICU and OR. The device sensor is a miniaturized blood gas analyzer integrated directly into the patient’s arterial line so that analyzed blood is returned to the patient. A dedicated bedside monitor with touch screen interface also provides simple, clear user-guiding routines.
With the new software drivers, users will be able to directly import diagnostics data from Proxima at patient bedside into Conworx’s POCcelerator, UniPOC middleware data management systems. In addition, the new interface will allow direct connectivity into CliniSys, a LIMS, through the CliniSys PoCT Solutions interface.
Both Conworx and CliniSys software solutions are being used in many hospitals globally, which would help ensure that data transfer from Proxima can be easily implemented, and its use and performance readily monitored remotely. Conworx’s middleware solutions provide connectivity, management, and integration for over 150 different POCT device types, as well as all relevant information and patient record systems. The Conworx base currently includes 1800 hospitals in 25 countries, and CliniSys software systems are used in over 2500 laboratories in 35 countries.
Sphere Medical CEO, Wolfgang Rencken, said: “This presents a huge step forward into integrating data from Proxima into laboratory information systems and electronic patient records. Partnering with Conworx allows our customers to use one middleware solution for all of their POC connectivity needs and greatly simplifies the implementation of Proxima within the hospital.”
Conworx CEO, Roman Rosenkranz, said: “We are delighted to be able to offer the first interface to an ex-vivo analyzer, which provides a seamless connection from the patient right through to the laboratory information system.”
Related Links:
Sphere Medical
Conworx Technology
The CE-marked Proxima blood analysis device from Sphere Medical (Cambridgeshire UK) can now be connected into the family of laboratory information system interfaces and data management solutions from Conworx Technology (Berlin, Germany). This is a significant development since it provides near real-time feedback and ensures seamless transfer of test results from Proxim directly into laboratory information management systems (LIMSs) and electronic patient records – a key requirement for the successful implementation of POC testing.
Proxima supports patient critical care, including in the ICU and OR. The device sensor is a miniaturized blood gas analyzer integrated directly into the patient’s arterial line so that analyzed blood is returned to the patient. A dedicated bedside monitor with touch screen interface also provides simple, clear user-guiding routines.
With the new software drivers, users will be able to directly import diagnostics data from Proxima at patient bedside into Conworx’s POCcelerator, UniPOC middleware data management systems. In addition, the new interface will allow direct connectivity into CliniSys, a LIMS, through the CliniSys PoCT Solutions interface.
Both Conworx and CliniSys software solutions are being used in many hospitals globally, which would help ensure that data transfer from Proxima can be easily implemented, and its use and performance readily monitored remotely. Conworx’s middleware solutions provide connectivity, management, and integration for over 150 different POCT device types, as well as all relevant information and patient record systems. The Conworx base currently includes 1800 hospitals in 25 countries, and CliniSys software systems are used in over 2500 laboratories in 35 countries.
Sphere Medical CEO, Wolfgang Rencken, said: “This presents a huge step forward into integrating data from Proxima into laboratory information systems and electronic patient records. Partnering with Conworx allows our customers to use one middleware solution for all of their POC connectivity needs and greatly simplifies the implementation of Proxima within the hospital.”
Conworx CEO, Roman Rosenkranz, said: “We are delighted to be able to offer the first interface to an ex-vivo analyzer, which provides a seamless connection from the patient right through to the laboratory information system.”
Related Links:
Sphere Medical
Conworx Technology
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Latest Hematology News
- Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
- First 4-in-1 Nucleic Acid Test for Arbovirus Screening to Reduce Risk of Transfusion-Transmitted Infections
- POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy
- First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy
- Handheld White Blood Cell Tracker to Enable Rapid Testing For Infections
- Smart Palm-size Optofluidic Hematology Analyzer Enables POCT of Patients’ Blood Cells
- Automated Hematology Platform Offers High Throughput Analytical Performance
- New Tool Analyzes Blood Platelets Faster, Easily and Accurately
- First Rapid-Result Hematology Analyzer Reports Measures of Infection and Severity at POC
- Bleeding Risk Diagnostic Test to Reduce Preventable Complications in Hospitals
- True POC Hematology Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput
- Point of Care CBC Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput
- Blood Test Could Predict Outcomes in Emergency Department and Hospital Admissions
- Novel Technology Diagnoses Immunothrombosis Using Breath Gas Analysis
- Advanced Hematology System Allows Labs to Process Up To 119 Complete Blood Count Results per Hour
- Unique AI-Based Approach Automates Clinical Analysis of Blood Data
Channels
Clinical Chemistry
view channel
3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more.jpg "Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)")
POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more
Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
The conventional methods for measuring free cortisol, the body's stress hormone, from blood or saliva are quite demanding and require sample processing. The most common method, therefore, involves collecting... Read more
Molecular Diagnostics
view channel
Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays
Osteoarthritis (OA) is the most prevalent form of arthritis, impacting millions worldwide and resulting in significant economic and social costs. Although no cure exists currently, the effectiveness of... Read more
Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans
Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more
Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset
Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more
Blood Test Could Detect HPV-Associated Cancers 10 Years before Clinical Diagnosis
Human papilloma virus (HPV) is known to cause various cancers, including those of the genitals, anus, mouth, throat, and cervix. HPV-associated oropharyngeal cancer (HPV+OPSCC) is the most common HPV-associated... Read moreImmunology
view channel
Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies
Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more
AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell
Current strategies for matching cancer patients with specific treatments often depend on bulk sequencing of tumor DNA and RNA, which provides an average profile from all cells within a tumor sample.... Read more
Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment
Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more
Microbiology
view channel
New CE-Marked Hepatitis Assays to Help Diagnose Infections Earlier
According to the World Health Organization (WHO), an estimated 354 million individuals globally are afflicted with chronic hepatitis B or C. These viruses are the leading causes of liver cirrhosis, liver... Read more
1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens
Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more
.jpg "Image: Dr. Sam Lodge found that metabolic signatures can shift the speed of sepsis diagnosis (Photo courtesy of Murdoch University)")
Pathology
view channel
First of Its Kind Universal Tool to Revolutionize Sample Collection for Diagnostic Tests
The COVID pandemic has dramatically reshaped the perception of diagnostics. Post the pandemic, a groundbreaking device that combines sample collection and processing into a single, easy-to-use disposable... Read more
AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis
The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance
Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Technology
view channel
New Diagnostic System Achieves PCR Testing Accuracy
While PCR tests are the gold standard of accuracy for virology testing, they come with limitations such as complexity, the need for skilled lab operators, and longer result times. They also require complex... Read more
DNA Biosensor Enables Early Diagnosis of Cervical Cancer
Molybdenum disulfide (MoS2), recognized for its potential to form two-dimensional nanosheets like graphene, is a material that's increasingly catching the eye of the scientific community.... Read more
Self-Heating Microfluidic Devices Can Detect Diseases in Tiny Blood or Fluid Samples
Microfluidics, which are miniature devices that control the flow of liquids and facilitate chemical reactions, play a key role in disease detection from small samples of blood or other fluids.... Read more
Breakthrough in Diagnostic Technology Could Make On-The-Spot Testing Widely Accessible
Home testing gained significant importance during the COVID-19 pandemic, yet the availability of rapid tests is limited, and most of them can only drive one liquid across the strip, leading to continued... Read moreIndustry
view channel
ECCMID Congress Name Changes to ESCMID Global
Over the last few years, the European Society of Clinical Microbiology and Infectious Diseases (ESCMID, Basel, Switzerland) has evolved remarkably. The society is now stronger and broader than ever before... Read more
Bosch and Randox Partner to Make Strategic Investment in Vivalytic Analysis Platform
Given the presence of so many diseases, determining whether a patient is presenting the symptoms of a simple cold, the flu, or something as severe as life-threatening meningitis is usually only possible... Read more
Siemens to Close Fast Track Diagnostics Business
Siemens Healthineers (Erlangen, Germany) has announced its intention to close its Fast Track Diagnostics unit, a small collection of polymerase chain reaction (PCR) testing products that is part of the... Read more